検索結果 - Hsing‐Hui Wang
- 検索結果 1 - 4 結果 / 4
-
1
Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers 著者: Wendy W. Hwang‐Verslues, Wen‐Hung Kuo, Po-Hao Chang, Chi-Chun Pan, Hsing‐Hui Wang, Sheng‐Ta Tsai, Yung‐Ming Jeng, Jin-Yu Shew, John T. Kung, Chung‐Hsuan Chen, Eva Y.-H.P. Lee, King‐Jen Chang, Wen‐Hwa Lee
出版事項 2009Artigo -
2
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity 著者: Pearl Bakhru, Menglei Zhu, Hsing‐Hui Wang, Lee K. Hong, Imran S. Khan, Maria L. Mouchess, Ajay Gulati, Joshua Starmer, Yafei Hou, David Sailer, Charles Lee, Fengmin Zhao, John M. Kirkwood, Stergios J. Moschos, Lawrence Fong, Mark S. Anderson, Maureen A. Su
出版事項 2017Artigo -
3
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer 著者: Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven Vensko, Mark G. Woodcock, Hsing‐Hui Wang, Sara E. Wobker, Gatphan Atassi, Alec Wilkinson, Kenneth A. Fowler, Leah M. Flick, Jeffrey S. Damrauer, Michael R. Harrison, Karen P. McKinnon, Tracy L. Rose, Matthew I. Milowsky, Jonathan S. Serody, William Y. Kim, Benjamin G. Vincent
出版事項 2024Artigo -
4
Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication 著者: Jared Weiss, Siddharth Sheth, Allison M. Deal, Juneko E. Grilley‐Olson, Samip Patel, Trevor Hackman, Jeffrey M. Blumberg, Thomas J. Galloway, Shetal Patel, Adam M. Zanation, Colette J. Shen, D. Neil Hayes, Christopher Hilliard, Ranee Mehra, Karen P. McKinnon, Hsing‐Hui Wang, Mark C. Weissler, Jessica R. Bauman, Bhishamjit S. Chera, Benjamin G. Vincent
出版事項 2020Artigo
関連主題
Cancer
Cancer research
Immunotherapy
Internal medicine
Medicine
Biology
Breast cancer
Chemotherapy
Immune checkpoint
Immune system
Immunology
Oncology
Pembrolizumab
Alternative medicine
Antibody
Biochemistry
Biomarker
Bladder cancer
Blockade
Blocking antibody
CD24
CD28
CD44
CTLA-4
Cancer stem cell
Cell
Cell biology
Cisplatin
Clinical endpoint
Clinical trial